Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 791 of 6351
-
Could stepping down breathing support sooner save more lives?
Disease control CompletedThis retrospective target trial emulation evaluates the optimal timing of de-escalation from controlled to assisted mechanical ventilation in critically ill adults. Using the clone-censor-weight (CCW) estimator with stabilised inverse-probability-of-censoring weights, we compare …
Sponsor: Ruijin Hospital • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Immunotherapy before surgery may help remove stubborn colon cancer
Disease control OngoingDue to dMMR colon cancer patients respond poorly to conventional chemotherapy, but immunotherapy can significantly improve the pCR in this group of patients, this study intends to explore whether neoadjuvant immunotherapy can improve the R0 resection rate with preservation of adj…
Phase 2 • Sponsor: Peking Union Medical College Hospital • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
New combo aims to tackle Hard-to-Treat breast cancer
Disease control Recruiting nowThis is a multicenter, single-arm, phase II clinical trial designed to evaluate the efficacy and safety of disitamab vedotin in combination with bevacizumab in patients with HER2-low advanced or metastatic breast cancer who have experienced disease progression following prior T-D…
Phase 2 • Sponsor: The First Affiliated Hospital with Nanjing Medical University • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
New antibody shows promise for tough thyroid eye disease
Disease control CompletedThis is an exploratory study of the efficacy and safety of IBI311, a modified anti-IGF-1R antibody, in patients with steroid-resistant, thyroid associated ophthalmopathy (TAO). This study includes two stages. Stage I is a single-center, single-arm, open-label clinical study desig…
Phase 3 • Sponsor: Peking University People's Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
A smartphone app may ease fibromyalgia — a 360-person trial investigates
Symptom relief Recruiting nowIntroduction: Fibromyalgia (FM) is a prevalent syndrome that lacks curative treatment, imposing high healthcare and societal costs. The SMART-FM-Spain study investigates the effectiveness, physiological effects, and cost-utility of a self-guided digital intervention (STANZA-Spain…
Sponsor: Fundació Sant Joan de Déu • Aim: Symptom relief
Last updated Jul 25, 2026 00:00 UTC
-
Do weighted blankets unlock better sleep for kids with ADHD?
Symptom relief Recruiting nowMany children with ADHD suffer from sleep disorders and dysfunction, which may affect development and well-being. According to the clinicians, some children find relief from restlessness and difficulty sleeping by using weighted blankets which have been proposed to reduce restles…
Sponsor: University Hospital Bispebjerg and Frederiksberg • Aim: Symptom relief
Last updated Aug 16, 2026 00:00 UTC
-
Can freezing tumors offer a new lifeline for head and neck cancer?
Disease control Recruiting nowIn France, squamous cell carcinomas of the head and neck (SCCHN) are the 5th most common cancer. 60% of patients present with locally advanced tumors (stage III/IV), characterized by a poor prognosis (5-year survival not exceeding 60%). The standard treatment consists of either s…
Sponsor: University Hospital, Strasbourg, France • Aim: Disease control
Last updated Aug 22, 2026 00:00 UTC
-
School lessons in emotional skills may shield teens from mental health struggles
Prevention OngoingHENKA is a universal, whole-community, school-based program that aims to promote emotional well-being and prevent mental health problems among adolescents enrolled in 1st to 3rd year of Secondary Education (ESO) in Catalonia, Spain (approximately 12 to 16 years old), through the …
Sponsor: Fundació Sant Joan de Déu • Aim: Prevention
Last updated Sep 06, 2026 00:00 UTC
-
Sound waves vs. seizures: new ultrasound trial for Hard-to-Treat epilepsy
Disease control Recruiting nowFocused ultrasound (FUS) has been shown to differentially lesion or modulate (excite and inhibit) brain circuit and neural activity across a broad range of acoustic stimulus parameters (intensity, duty cycle, pulse repetition frequency and pulse duration) for decades. From our pr…
Sponsor: Taipei Veterans General Hospital, Taiwan • Aim: Disease control
Last updated Jun 26, 2026 14:30 UTC
-
New hope for VHL patients: belzutifan trial targets rare tumor disorder
Disease control Recruiting nowThe BELIEVE-VHL Trial is a prospective real-life study designed to evaluate the therapeutic effects, benefits, and adverse effects of belzutifan, as well as the timing of treatment response and disease progression in patients with von Hippel-Lindau (VHL) syndrome.
Phase 2 • Sponsor: José Claudio Casali da Rocha • Aim: Disease control
Last updated Jun 26, 2026 15:43 UTC
-
New radioactive drug takes aim at Hard-to-Treat prostate cancer
Disease control By invitation onlyThis study will determine the safe initial injected activity of the radioligand therapy 177Lu-HTK03170 for the measurement of dosimetry and initiation of treatment in subjects with PSMA-positive, metastatic castrate resistant prostate cancer, (mCRPC). Subjects will receive treatm…
Phase 1/2 • Sponsor: British Columbia Cancer Agency • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
Engineered immune cells take on advanced cancers in early trial
Disease control Recruiting now1. Study Title: Efficacy and safety of MSLN CAR-T in advanced malignant tumors 2. Study Objectives: Primary: To evaluate the safety and tolerability of MSLN-targeted CAR-T cell therapy in patients with stage III/IV advanced malignant tumors. Secondary: To preliminaril…
Phase 1/2 • Sponsor: Shenzhen University General Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
New drug combo shows promise for rare childhood leukemia
Disease control OngoingThis is a prospective, single-arm, open-label clinical study to evaluate the efficacy and safety of Selinexor combined with a standardized induction chemotherapy regimen (ZJCH-AML) for children with NUP98-fusion positive Acute Myeloid Leukemia (AML). NUP98-fusion positive AML is…
Phase 2 • Sponsor: The Children's Hospital of Zhejiang University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Home ultrasound pushing practice: a new way to ease childbirth?
Disease control Recruiting nowA substantial number of women report fear of childbirth and negative birth experiences. The objective of the study is to assess the efficacy of visual biofeedback before labor using a self-operated home ultrasound for maternal pushing training, which is expected to reduce fear of…
Sponsor: Rabin Medical Center • Aim: Disease control
Last updated Aug 20, 2026 00:00 UTC
-
New hope for tough prostate cancer: experimental drug takes on standard treatments
Disease control Recruiting nowThis is a phase 3, randomized, open-label study of opevesostat compared to alternative abiraterone acetate or enzalutamide in participants with metastatic castration-resistant prostate cancer (mCRPC) with respect to overall survival (OS) in participants with mCRPC previously trea…
Phase 3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
New hope for blood disorder patients: experimental drug bomedemstat enters final trial phase
Disease control OngoingThis is a study evaluating the safety and efficacy of bomedemstat (MK-3543) compared with the best available therapy (BAT) in participants with essential thrombocythemia (ET) who have an inadequate response to or are intolerant of hydroxyurea. The primary study hypothesis is that…
Phase 3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
New combo shrinks untouchable liver tumors, opens door to surgery
Disease control Recruiting nowThis is an open-label, single-arm, phase 2 study evaluating hepatic arterial infusion chemotherapy (HAIC) combined with lenvatinib and cadonilimab as conversion therapy for initially unresectable hepatocellular carcinoma (HCC). The primary objective is to assess the conversion ra…
Phase 2 • Sponsor: Tongji Hospital • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
New chemo cocktail aims to shrink hard-to-treat childhood muscle cancer
Disease control Recruiting nowThis multicenter, randomized, controlled, open-label, prospective clinical trial was designed to evaluate the efficacy and safety of doxorubicin hydrochloride liposome injection in combination with irinotican (AI regimen) versus VIT regimen in the treatment of relapsed and refrac…
Phase 2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
New hope for tough lymphomas: experimental drug targets cancer protein
Disease control Recruiting nowThe purpose of this study is to evaluate the safety, tolerability, drug levels, and preliminary biological and clinical activity of BMS-986458, a bifunctional cereblon-dependent ligand-directed degrader of B-cell lymphoma 6 (BCL6), as a single agent and in combination with anti-l…
Phase 1/2 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Aug 20, 2026 00:00 UTC
-
New triple therapy hopes to tame tough breast cancer
Disease control Recruiting nowThe purpose of this study is to test whether the combination of lenvatinib, pembrolizumab, and fulvestrant is a safe and effective treatment that causes few or mild side effects in people with ER+/HER2- metastatic breast cancer.
Phase 1/2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC